QQ客服 官方微博 反馈留言

	Therapeutic Drug Monitoring of Teicoplanin in Haematological Malignancy Patients with Febrile Neutropenia and Optimizing Dosage Regimens
	Hu, Sasa; Wang, Taotao; You, Haisheng; Wei, Shuangyu; Song, Hongjuan; Zhang, Tao; Zhang, Di; Dong, Yalin
刊名	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
	2018
卷号	123页码:594-601
ISSN号	1742-7835
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2829984
专题	西安交通大学
推荐引用方式 GB/T 7714	Hu, Sasa,Wang, Taotao,You, Haisheng,et al. Therapeutic Drug Monitoring of Teicoplanin in Haematological Malignancy Patients with Febrile Neutropenia and Optimizing Dosage Regimens[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY,2018,123:594-601.
APA	Hu, Sasa.,Wang, Taotao.,You, Haisheng.,Wei, Shuangyu.,Song, Hongjuan.,...&Dong, Yalin.(2018).Therapeutic Drug Monitoring of Teicoplanin in Haematological Malignancy Patients with Febrile Neutropenia and Optimizing Dosage Regimens.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY,123,594-601.
MLA	Hu, Sasa,et al."Therapeutic Drug Monitoring of Teicoplanin in Haematological Malignancy Patients with Febrile Neutropenia and Optimizing Dosage Regimens".BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 123(2018):594-601.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。